Faster α-synuclein seeding in cerebrospinal fluid signaled a higher risk of cognitive decline in Parkinson’s disease.

CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...

This Case Study describes a 80-year-old patient with lower-body parkinsonism who was diagnosed with vascular parkinsonism on the basis of clinical and neuroimaging findings, but whose gait and, to ...

He subsequently developed a parkinsonism syndrome with hallmark symptoms. After his olanzapine dosage was reduced to 20 mg daily, the patient's symptoms improved.

Olanzapine 30 mg orally daily was initiated; after five weeks of olanzapine treatment, the patient decided to reduce his daily smoking from 40 to 10 cigarettes. He subsequently developed a ...

Purpose. The case of a patient taking high-dosage olanzapine who experienced parkinsonism after smoking cessation is reported. Summary. A 73-year-old Caucasian woman with a recent diagnosis of ...

From making accusations to usage of foul language, dementia can bring about unsettling behavioural changes in a loved one.

Parkinsonism can have many causes, among them cerebrovascular disease. Vascular parkinsonism can be caused by infarction or haemorrhage in the nigrostriatal pathway, resulting in hemiparkinsonism, or ...

Conclusions 22q11.2DS is characterised by left-handedness and neuropsychiatric features such as cognitive impairment, schizophrenia, epilepsy and parkinsonism. GGE, mostly the JME phenotype, is the ...

Neuroferritinopathy produces iron deposition in the basal ganglia, but serum ferritin levels are often low. The disease can give rise to parkinsonism, but shows greater phenotypic resemblance to ...

Vascular parkinsonism (VaP) is a subtype of parkinsonism which needs better characterization of its risks and determinants.The aim of this report is to present an understanding of genetic risks of ...